Natural Product-Derived Treatments of Neuropsychiatric Disorders: Review of Progress and Recommendations

作者: James Lake

DOI: 10.1016/S1572-5995(00)80060-5

关键词:

摘要: Abstract Most currently used psychotropic agents have limited efficacy, significant side-effect and toxicity problems, are unavailable to approximately 80% of the World's population. The development efficacious safe medications based on naturally occurring substances in non-allopathic healing traditions would represent a contribution global mental health care. Rigorous empirical validation indigenous treatments for neuopsychiatric symptoms syndromes is necessary ensure that goals safety efficacy achieved. With these view, present monograph reviews discusses important historical, scientific, cross-cultural legal-regulatory aspects as neuropsychiatric disorders. design systematic review published scientific literature controlled studies (using Napralert database) described. Limitations identified possible solutions Significant findings discussed developed into framework further analysis. Six CNS activity categories selected in-depth because their central relevance common or syndromes. In main body synoptic reviews, including summary exhibits, provided current status recent research, in-vitro, animal human clinical trials investigating treatment seizure disorders, schizophrenia, dementia age-related cognitive decline, unipolar depression other mood anxiety states, substance abuse dependence. Substantial evidence advanced many natural products employed systems medicine treat neuropsychiatrie Many empirically validated appear efficacies comparable superior synthetic agents. concludes with recommendations offered facilitating improved networking, accelerating promising research directions, enhancing quality standards ethnopharmacologic investigations putative

参考文章(19)
Ara Harold Der Marderosian, Lawrence E. Liberti, Natural product medicine: A scientific guide to foods, drugs, cosmetics ,(1988)
G. Andrews, N. Sartorius, G. De Girolamo, Treatment of mental disorders : a review of effectiveness Psychothérapies. ,vol. 14, pp. 169- 170 ,(1993)
William Charles Evans, Trease and Evans' Pharmacognosy ,(1978)
Carolyn Fishel Sargent, Thomas M. Johnson, Medical Anthropology: Contemporary Theory and Method ,(1996)
R. E. Schultes, S. von Reis, Ethnobotany: Evolution of a Discipline ,(1995)
B. Weniger, Interest and limitation of a global ethnopharmacological survey. Journal of Ethnopharmacology. ,vol. 32, pp. 37- 41 ,(1991) , 10.1016/0378-8741(91)90101-I
R. Anton, Y. Jiang, B. Weniger, J.P. Beck, L. Rivier, Pharmacognosy of Mimosa tenuiflora (Willd.) Poiret. Journal of Ethnopharmacology. ,vol. 38, pp. 145- 152 ,(1993) , 10.1016/0378-8741(93)90010-3
David M. Turner, Natural product source material use in the pharmaceutical industry: the Glaxo experience Journal of Ethnopharmacology. ,vol. 51, pp. 39- 44 ,(1996) , 10.1016/0378-8741(95)01348-2
Norman R. Farnsworth, Ethnopharmacology and future drug development: the North American experience. Journal of Ethnopharmacology. ,vol. 38, pp. 137- 143 ,(1993) , 10.1016/0378-8741(93)90009-T
Peter A.G.M. De Smet, An introduction to herbal pharmacoepidemiology. Journal of Ethnopharmacology. ,vol. 38, pp. 189- 195 ,(1993) , 10.1016/0378-8741(93)90016-X